Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

According to the EC-Regulation 1272/2008 and subsequent regulations, SymMollient® S is not classified as a skin sensitiser.

Migrated from Short description of key information:
Magnusson and Kligman Study according to OECD 406 was performed. An expert statement is provided as attached document (see above).

Justification for classification or non-classification